{"id":"tp-48961","type":"article-newspaper","title":"Royalty Pharma Raises 2026 Receipts Outlook After 9% Q3 Growth","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/48961","datePublished":"2026-11-05T02:17:58.000Z","dateModified":"2026-11-05T02:17:58.000Z","language":"en","abstract":"Royalty Receipts rose to $883 million, while net income attributable to the company fell to $144.7 million.","section":"Business","references":[{"title":"results date announcement","url":"https://www.tokenpost.com/news/business/28967"}]}